Line Wergeland

443 total citations
13 papers, 386 citations indexed

About

Line Wergeland is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Line Wergeland has authored 13 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 6 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Line Wergeland's work include Acute Myeloid Leukemia Research (8 papers), Cell death mechanisms and regulation (2 papers) and Advanced Proteomics Techniques and Applications (2 papers). Line Wergeland is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Cell death mechanisms and regulation (2 papers) and Advanced Proteomics Techniques and Applications (2 papers). Line Wergeland collaborates with scholars based in Norway, United Kingdom and Kenya. Line Wergeland's co-authors include Bjørn Tore Gjertsen, Øystein Bruserud, Nils Glenjen, Randi Hovland, Anita Ryningen, Tien‐sheng Huang, Jørn Skavland, Olav Karsten Vintermyr, Emmet McCormack and Anne Christine Johannessen and has published in prestigious journals such as PLoS ONE, Molecular Cancer and Journal of Clinical Medicine.

In The Last Decade

Line Wergeland

13 papers receiving 382 citations

Peers

Countries citing papers authored by Line Wergeland

Since Specialization

Citations

This map shows the geographic impact of Line Wergeland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Line Wergeland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Line Wergeland more than expected).

Fields of papers citing papers by Line Wergeland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Line Wergeland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Line Wergeland. The network helps show where Line Wergeland may publish in the future.

Co-authorship network of co-authors of Line Wergeland

This figure shows the co-authorship network connecting the top 25 collaborators of Line Wergeland. A scholar is included among the top collaborators of Line Wergeland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Line Wergeland. Line Wergeland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	FLT3‐ITD mutations in acute myeloid leukaemia – molecular characteristics, distribution and numerical variation 2021 ·Molecular Oncology ·(unknown), Monica Hellesøy, Tim Grob, Adil Al Hinai, (unknown), Line Wergeland, (unknown), Randi Hovland, Peter J.M. Valk, Bjørn Tore Gjertsen	6
2	Targeted Therapy of FLT3 in Treatment of AML—Current Status and Future Directions 2014 ·Journal of Clinical Medicine ·(unknown), Line Wergeland, Jørn Skavland, Bjørn Tore Gjertsen	8
3	Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53null Cell Lines 2013 ·PLoS ONE ·(unknown), (unknown), Line Wergeland, André Sulen, Vibeke Andresen, Jean‐Christophe Bourdon, David Micklem, Emmet McCormack, Bjørn Tore Gjertsen	26
4	Ectopic expression of Flt3 kinase inhibits proliferation and promotes cell death in different human cancer cell lines 2012 ·Cell Biology and Toxicology ·Eystein Oveland, Line Wergeland, Randi Hovland, James B. Lorens, Bjørn Tore Gjertsen, Kari E. Fladmark	9
5	Camptothecin and khat (Catha edulis Forsk.) induced distinct cell death phenotypes involving modulation of c-FLIPL, Mcl-1, procaspase-8 and mitochondrial function in acute myeloid leukemia cell lines 2009 ·Molecular Cancer ·(unknown), (unknown), Hanne R. Hagland, Line Wergeland, Jørn Skavland, (unknown), Karl Johan Tronstad, Anne Christine Johannessen, Olav Karsten Vintermyr, Bjørn Tore Gjertsen	46
6	Ligand-induced Flt3-downregulation modulates cell death associated proteins and enhances chemosensitivity to idarubicin in THP-1 acute myeloid leukemia cells 2008 ·Leukemia Research ·Eystein Oveland, Bjørn Tore Gjertsen, Line Wergeland, Frode Selheim, Kari E. Fladmark, Randi Hovland	14
7	Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells 2007 ·Molecular Cancer ·Line Wergeland, (unknown), Ingvild Haaland, Randi Hovland, Øystein Bruserud, Bjørn Tore Gjertsen	17
8	Proteomics Approaches to Elucidate Oncogenic Tyrosine Kinase Signalingin Myeloid Malignancies 2006 ·Current Pharmaceutical Biotechnology ·Eystein Oveland, (unknown), Line Wergeland, Bjørn Tore Gjertsen, Randi Hovland	3
9	Proteomics in Acute Myelogenous Leukaemia (AML): Methodological Strategies and Identification of Protein Targets for Novel Antileukaemic Therapy 2005 ·Current Drug Targets ·(unknown), Nina Ånensen, Line Wergeland, Emmet McCormack, Øystein Bruserud, Bjørn Tore Gjertsen	11
10	In vitro crosstalk between fibroblasts and native human acute myelogenous leukemia (AML) blasts via local cytokine networks results in increased proliferation and decreased apoptosis of AML cells as well as increased levels of proangiogenic Interleukin 8 2004 ·Leukemia Research ·Anita Ryningen, Line Wergeland, Nils Glenjen, Bjørn Tore Gjertsen, Øystein Bruserud	61
11	Osteoblasts increase proliferation and release of pro-angiogenic interleukin 8 by native human acute myelogenous leukemia blasts. 2004 ·PubMed ·Øystein Bruserud, Anita Ryningen, Line Wergeland, Nils Glenjen, Bjørn Tore Gjertsen	78
12	Flt3-mediated signaling in human acute myelogenous leukemia (AML) blasts: a functional characterization of Flt3-ligand effects in AML cell populations with and without genetic Flt3 abnormalities. 2003 ·PubMed ·Øystein Bruserud, Randi Hovland, Line Wergeland, Tien‐sheng Huang, Bjørn Tore Gjertsen	93
13	The angioregulatory phenotype of native human acute myelogenous leukemia cells: influence of karyotype, Flt3 abnormalities and differentiation status 2003 ·European Journal Of Haematology ·Nils Glenjen, Randi Hovland, Line Wergeland, Øystein Wendelbo, Peter Ernst, Øystein Bruserud	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact